Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IKT Inhibikase Therapeutics

0.900
+0.013+1.47%
Close 10/05 16:00 ET
High
0.938
Open
0.895
Turnover
77.30K
Low
0.860
Pre Close
0.887
Volume
88.72K
Market Cap
22.70M
P/E(TTM)
Loss
52wk High
2.340
Shares
25.23M
P/E(Static)
Loss
52wk Low
0.600
Float Cap
16.46M
Bid/Ask %
0.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
3.57
Historical Low
0.600
Dividend TTM
--
Div Yield TTM
--
P/B
0.77
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.49%
Amplitude
8.75%
Avg Price
0.871
Lot Size
1
Float Cap
16.46M
Bid/Ask %
0.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
3.57
Historical Low
0.600
Dividend TTM
--
P/B
0.77
Dividend LFY
--
Turnover Ratio
0.49%
Amplitude
8.75%
Avg Price
0.871
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP? Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
CEO: Dr. Milton H. Werner, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...